Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2005 1
2006 1
2007 3
2008 3
2009 2
2010 4
2011 4
2012 6
2013 11
2014 14
2015 20
2016 19
2017 27
2018 14
2019 17
2020 22
2021 31
2022 26
2023 19
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Predictive factors for postoperative delirium in thoracic surgery.
Yaguchi T, Ichinokawa H, Kirino E, Suzuki M, Komori K, Matsunaga T, Takamochi K, Suzuki K. Yaguchi T, et al. Among authors: takamochi k. Gen Thorac Cardiovasc Surg. 2024 Mar 21. doi: 10.1007/s11748-024-02014-0. Online ahead of print. Gen Thorac Cardiovasc Surg. 2024. PMID: 38512455
Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial.
Takamochi K, Haruki T, Oh S, Endo M, Funai K, Kitamura Y, Tsuboi M, Tsukioka T, Suzuki H, Ito H, Okumura N, Ueno T, Ikeda N, Iwata H, Okada M, Ichikawa T, Okamoto T, Nojiri S, Suzuki K; Advanced Clinical Trial Chest Surgery Group. Takamochi K, et al. J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01007-3. doi: 10.1016/j.jtcvs.2023.10.050. Online ahead of print. J Thorac Cardiovasc Surg. 2023. PMID: 38348845
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
Hattori A, Suzuki K, Takamochi K, Wakabayashi M, Sekino Y, Tsutani Y, Nakajima R, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Nakamura K, Fukuda H, Watanabe SI; Japan Clinical Oncology Group; West Japan Oncology Group. Hattori A, et al. Among authors: takamochi k. Lancet Respir Med. 2024 Feb;12(2):105-116. doi: 10.1016/S2213-2600(23)00382-X. Epub 2024 Jan 3. Lancet Respir Med. 2024. PMID: 38184010 Clinical Trial.
205 results